8-K: Core Scientific Bankruptcy Plan Confirmed, Paving Way for Nasdaq Relisting

Core Scientific's Chapter 11 reorganization plan has been confirmed by the Bankruptcy Court, setting the stage for the company's emergence and relisting on Nasdaq.

Summary

• Core Scientific's bankruptcy reorganization plan was confirmed by the Bankruptcy Court on January 16, 2024.
• The plan includes a restructuring that will cancel all outstanding shares of the company's common stock and issue approximately 166 million new shares.
• Approximately 17.9 million of the new shares will be issued in connection with an Equity Rights Offering, which was oversubscribed, raising $55 million.
• Holders of April and August Convertible Notes will receive new secured notes, new secured convertible notes, and a share of the Convertible Noteholders Equity Distribution.
• Miner Equipment Lenders will receive new common stock or takeback debt, depending on their election.
• General Unsecured Claim holders will receive new common stock, a share of the GUC Settlement Additional Equity Distribution Amount, and a share of the GUC Contingent Payment Obligations.
• Holders of Existing Common Interests will receive a share of the Residual Equity Pool and New Warrants.
• The company intends to apply to list the New Common Stock on the Nasdaq Global Market.
• The plan also includes a restructuring that provides for the treatment of certain classes of claims and interests.
• The company expects to emerge from Chapter 11 by the end of January 2024.

Sentiment

Score: 7

Explanation: The document conveys a positive sentiment due to the successful confirmation of the reorganization plan, the oversubscribed equity rights offering, and the company's intention to relist on Nasdaq. However, the underlying bankruptcy and the risks associated with the restructuring process temper the overall sentiment.

Positives

• The company has successfully completed an oversubscribed $55 million Equity Rights Offering.
• The company has fully paid off its DIP financing.
• The company is poised to emerge from Chapter 11 by the end of January 2024.
• The company intends to relist on the Nasdaq Global Market.

Negatives

• All outstanding shares of the company's common stock will be cancelled.
• The company has been operating under Chapter 11 bankruptcy since December 21, 2022.

Risks

• The company's ability to obtain Bankruptcy Court approval with respect to motions in its Chapter 11 Cases is a risk.
• The company's ability to successfully implement a restructuring plan and emerge from Chapter 11 is a risk.
• The effects of the Chapter 11 Cases on the company and on the interests of various constituents is a risk.
• Bankruptcy Court rulings in the Chapter 11 Cases and the outcome of the Chapter 11 Cases in general is a risk.
• The length of time the company will operate under the Chapter 11 Cases is a risk.
• Risks associated with any third-party motions in the Chapter 11 Cases is a risk.
• The potential adverse effects of the Chapter 11 Cases on the company's liquidity or results of operations and increased legal and other professional costs necessary to execute the company's reorganization is a risk.
• Finalization and receipt of the replacement debtor-in-possession facility is a risk.
• Satisfaction of any conditions to which the company's debtor-in-possession financing is subject and the risk that these conditions may not be satisfied for various reasons, including for reasons outside of the company's control is a risk.
• The consequences of the acceleration of the company's debt obligations is a risk.
• The trading price and volatility of the company's common stock and the risks related to trading on the OTC Pink Market is a risk.

Future Outlook

The company is poised to emerge from Chapter 11 by the end of January 2024 and intends to apply to list the New Common Stock on the Nasdaq Global Market.

Management Comments

• With demand for Bitcoin and high-value compute continuing to rise, we look forward to creating value for our shareholders as we execute our growth plan, de-lever our balance sheet and deliver superior efficiency at scale, said Adam Sullivan, Core Scientific Chief Executive Officer.

Industry Context

The announcement comes amid a period of increasing demand for Bitcoin and high-value compute, suggesting a positive outlook for the company's future operations.

Comparison to Industry Standards

• The document does not provide specific details on the company's performance compared to industry standards.
• The document does not provide specific details on the company's performance compared to competitors.
• The document does not provide specific details on the company's performance compared to global benchmarks.

Legal Proceedings

• The company filed voluntary petitions for relief under Chapter 11 of the Bankruptcy Code on December 21, 2022.

Stakeholder Impact

• Shareholders will receive new common stock and warrants, constituting approximately 60% of the company's new equity.
• Holders of April and August Convertible Notes will receive new secured notes, new secured convertible notes, and a share of the Convertible Noteholders Equity Distribution.
• Miner Equipment Lenders will receive new common stock or takeback debt, depending on their election.
• General Unsecured Claim holders will receive new common stock, a share of the GUC Settlement Additional Equity Distribution Amount, and a share of the GUC Contingent Payment Obligations.
• Holders of Existing Common Interests will receive a share of the Residual Equity Pool and New Warrants.

Next Steps

• The company will implement the restructuring plan.
• The company will issue new common stock and warrants.
• The company will apply to list the New Common Stock on the Nasdaq Global Market.
• The company will emerge from Chapter 11 by the end of January 2024.

Key Dates

Keywords

bankruptcy, reorganization, Chapter 11, Core Scientific, Nasdaq, restructuring, convertible notes, common stock, equity rights offering, secured notes